Drug-pricing pressure from US warrants EU anti-coercion response, Belgian minister says
( October 30, 2026, 15:36 GMT | Official Statement) -- MLex Summary: The EU should use its anti-coercion instrument to counter US pressure on European medicine prices, the Belgian health minister has argued in a paper. Frank Vandenbroucke warns that linking US drug prices to those paid in Europe risks raising European healthcare costs and restricting access to medicines, and calls for a collective EU response. The EU should also suspend tariff concessions under the Turnberry agreement if Washington imposes additional duties over national drug-pricing policies, the paper says.The statement is attached....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.